Victory Capital Management’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
|
|||||
2025
Q1 | $3.56K | Sell |
|
|||||
2024
Q4 | $15.3K | Sell |
|
|||||
2024
Q3 | $21.7K | Sell |
|
|||||
2024
Q2 | $23.9K | Sell |
|
|||||
2024
Q1 | $54.1K | Sell |
|
|||||
2023
Q4 | $29.5K | Buy |
|
|||||
2022
Q3 | – | Sell |
|
|||||
2022
Q2 | $58K | Buy |
|
|||||
2022
Q1 | $36K | Buy |
|
|||||
2021
Q2 | – | Sell |
|
|||||
2021
Q1 | $305K | Sell |
|
|||||
2020
Q4 | $786K | Buy |
|
|||||
2020
Q3 | $362K | Buy |
|
|||||
2020
Q2 | $213K | Sell |
|
|||||
2020
Q1 | $64K | Buy |
|
|||||
2019
Q4 | – | Sell |
|
|||||
2019
Q3 | $10K | Buy |
|
|||||
2018
Q1 | – | Sell |
|
|||||
2017
Q4 | $952K | Buy |
|
|||||
2017
Q3 | $903K | Sell |
|
|||||
2017
Q2 | $754K | Buy |
|